Skip to main content Skip to main navigation menu Skip to site footer

Journal Information

About the Journal

Indonesia Journal of Biomedical Science is published by Intisari Sains Medis with the help of DiscoverSys Inc., (Canada). IJBS, Print-ISSN 2085-4773; E-ISSN 2302-2906 is an open-access, peer-reviewed, international journal aiming to communicate high-quality research articles and reviews related to biomedicine development.

Postgraduate School of Biomedicine, Udayana University was the early co-collaborator of IJBS agreed that the study published in our journal needs to be related or conducted in biomedicine laboratory.

Today, IJBS. requires all published articles to be from the 3 major departments of Udayana biomedicine (see list) or from the 8 departement of UGM biomedicine (see list). Nonrelated topics and non-laboratory-based research will be automatically rejected.

Four main accepted article characteristics include:

  1. Original Articles: Experimental/Observational study that involves samples and control groups.
  2. Review Articles: Systematic review or Meta-analysis in a hospital based condition.
  3. Case: Hospital Case Reports or Case Series that usually inform about rare cases, emerging cases, or rare procedures (surgery and non-surgery).
  4. Editorial Letter: Commentaries related to a published article, usually with different points of view/ expert opinions.

 

The journal also accepts innovation reports in biomedicine development, survey articles, practical guidelines, and animal models (strictly related to biomedicine, etc: drug testing).

IJBS also aims to bridge and integrate medical scholarship's intellectual, translational medicine, methodological, and substantive diversity and encourage a vigorous dialogue between medical scholars and medical researchers. The Journal welcomes contributions that promote the exchange of ideas and rational discourse between practicing educators and medical researchers worldwide.

 

About Postgraduate School of Biomedicine - Udayana University

With the vision to become a Center for Development and Education in Biomedical Science, especially Anti-Aging Medicine to produce graduates who are excellent, independent, civilized and have global competitive advantage in Indonesia" the postgraduate Institute of Udayana University was established in 1999.

To achieve that vision, some missions of Biomedical Science Master Study Program of  Unud were formulated from the missions of Gradute Program  of  Udayana University,

  • to hold education in Biomedical Science in master level effectively and efficiently.
  • to strengthen institution’s capacity as the center of Biomedical Science development.
  • to improve partnership with government and private institutions to participate in entrepreneurship development.

 

DiscoverSys Inc. and eJournals

DiscoverSys is a Canadian based Pharmaceutical and Biomedical Research Consulting Company having its corporate office in Edmonton. eJournals, a not-for-profit venture and the scholarly publishing services of DiscoverSys, uses the Open Journal Systems (OJS) and creates a platform for researchers and associations to publish their quality research with an international reach. eJournals is a brainchild of dedicated professionals who have years of experience in biomedical research and publishing with an objective of helping the academic community to effectively utilize the OJS platform . Needless to say, we love open source and we are dedicated to Open Journal Systems (OJS) and Ambra (by PLOS). Our team comprises of biomedical scientists who understand the intricacies of academic publishing and creative and enthusiastic coders capable of fulfilling whatever OJS-related desire you might have, from simple solutions to top-level theme and plugin customizations. Our team of highly trained academic scientists, programmers and experienced project managers who have created hundreds of websites combine good old-fashioned service with cutting edge technology to keep our clients ahead

DiscoverSys Specialties

Online Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Emerging Open Access Publisher

  

Acknowledgement

Open Journal Systems (commonly known as OJS) is a journal management and publishing system that has been developed by the Public Knowledge Project through its federally funded efforts to expand and improve access to research. Public Knowledge Project is a multi-university initiative developing (free) open source software and conducting research to improve the quality and reach of scholarly publishing. This journal and DiscoverSys acknowledge the creativity and effots by the Public Knowledge Project team on developing and continuously upgrading OJS. Please visit the Public Knowledge Project Official Website to know more and to support the inititives of Public Knowledge Project.


Proofread by:

http://www.discoversys.ca/

 

Spelling and grammar error check with:

Grammarly® Premium

 

Screening for Plagiarism Policy

Bali Med. J. has a policy of screening for plagiarism. We use Anti-Plagiarism Software "Turnitin" to check the authenticity article

 

Deposit Policy Directory

Sherpa/Romeo 

 

Archiving Policy

 This journal on digital archiving policy to Portal Garuda, click here

 

Content Ownership, Licensing, Copyright, and Permissions

Once published the authors transfer the copyright to the publishers, but we allow certain rights to their authors (the ability to reuse parts of the paper in the author's future work and allow the author to distribute a limited number of copies) based on the rules and regulations of the license under a Creative Commons Attribution-BY

You are free to:

  • Share — copy and redistribute the material in any medium or format
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

All authors are Free to Submit, 
and Free to Publish only for eligible authors with High H-Index and citations, with no Grant and Funding from any Institution, University, Organisation, and Government (Proven by a letter from the Head Department, Dean, or Rector).

Due to the global pandemic, our review process may vary from 30 to 90 days.